Boston Scientific (BSX) Invested Capital (2009 - 2026)

Boston Scientific has disclosed Invested Capital across 18 years of filings, most recently posting $37.8 billion for Q2 2026.

• In Q2 2026, Invested Capital rose 10.39% year-over-year to $37.8 billion; the TTM figure through Jun 2026 stood at $37.8 billion (up 10.39% YoY), while the FY2025 annual figure was $35.9 billion, up 9.65% from the prior year.
• Invested Capital came in at $37.8 billion for Q2 2026 at Boston Scientific, up from $37.1 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $37.8 billion in Q2 2026 to a low of $26.0 billion in Q1 2022.
• Average Invested Capital over 5 years is $30.9 billion, with a median of $31.0 billion recorded in 2024.
• Year-over-year, Invested Capital rose 2.65% in 2022 and gained 14.38% in 2024.
• Over 5 years, Invested Capital stood at $26.5 billion in 2022, then increased by 8.01% to $28.6 billion in 2023, then climbed by 14.38% to $32.7 billion in 2024, then gained by 9.65% to $35.9 billion in 2025, then climbed by 5.26% to $37.8 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $37.8 billion in Q2 2026, $37.1 billion in Q1 2026, and $35.9 billion in Q4 2025.